New eczema ointment shows promise in early trial
Symptom relief
Recruiting now
This Phase 2 study tests an experimental ointment called GX-03 in adults with moderate-to-severe eczema. About 110 to 200 participants will apply either the active ointment or a placebo for 8 weeks. Researchers will measure improvements in skin rash, itch, and patient-reported sy…
Phase: PHASE2 • Sponsor: Turn Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC